This inventor holds 2 USPTO granted patents. Top assignee: Hangzhou Dinova Ep Technology Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jianglang Zhao: Innovator in Vascular Occlusion Technology
Introduction
Jianglang Zhao is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of medical technology, particularly in the development of devices for occluding defects in the vascular system. With a total of 2 patents, Zhao's work is paving the way for advancements in minimally invasive procedures.
Latest Patents
Zhao's latest patents include innovative designs for an occluder and an occluding system. The first patent describes an occluder that is specifically designed to occlude a defect in the vasculature. This occluder consists of two occluding disks and a tightening element, which allows for adjustable tension to effectively cover different openings of the defect. The second patent further elaborates on the occluder, detailing a tightening wire that passes through a connector on the first occlusion disc, enabling precise adjustments to the distance between the two occlusion discs.
Career Highlights
Jianglang Zhao is currently employed at Hangzhou Dinova Ep Technology Co., Ltd., where he continues to innovate in the field of medical devices. His work focuses on creating solutions that enhance the safety and efficacy of vascular interventions. Zhao's inventions are crucial for improving patient outcomes in procedures that require occlusion of vascular defects.
Collaborations
Zhao collaborates with talented professionals in his field, including Jie Chen and Yongsheng Wang. These partnerships foster a creative environment that encourages the development of cutting-edge medical technologies.
Conclusion
Jianglang Zhao's contributions to vascular occlusion technology demonstrate his commitment to advancing medical science. His innovative patents and collaborative efforts are set to make a lasting impact on the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile